InsidersTradesSigma
Total declarations
Company
▲ Purchases (10 ops.)
▼ Sales (55 ops.)
Insider track record
CEODisclosed buys
10
Disclosed sells
55
T+90 hit rate
60%
T+90 mean return
+20.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Medpace Investors, LLC, Chief Executive Officer & Chairman of the Board. Director active across 1 company, notably Medpace Holdings, Inc.. In total, 65 filings have been recorded. Breakdown: 10 buys · 55 sells. Total volume traded: €409.8m. Activity tracked since 15 June 2021. The latest transaction was filed on 6 March 2024 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Medpace Investors, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations65 total
100,000 shares@ US$412.987.7% of flowCommon StockSEC:0001668397-24-000055:0
50,000 shares@ US$403.123.8% of flowCommon StockSEC:0001668397-24-000047:0
20,000 shares@ US$393.711.5% of flowCommon StockSEC:0001668397-24-000045:0
50,000 shares@ US$401.883.8% of flowCommon StockSEC:0001668397-24-000033:0
100,000 shares@ US$400.327.5% of flowCommon StockSEC:0001668397-24-000025:0
36,012 shares@ US$383.442.6% of flowCommon StockSEC:0001668397-24-000023:0
50,000 shares@ US$391.753.7% of flowCommon StockSEC:0001668397-24-000017:0
3,167 shares@ US$272.870.2% of flowCommon StockSEC:0000892251-23-000194:0
25,000 shares@ US$276.101.3% of flowCommon StockSEC:0000892251-23-000193:0
25,000 shares@ US$277.811.3% of flowCommon StockSEC:0000892251-23-000189:0
25,000 shares@ US$277.371.3% of flowCommon StockSEC:0000892251-23-000187:0
50,000 shares@ US$273.912.6% of flowCommon StockSEC:0000892251-23-000185:0
25,000 shares@ US$283.111.3% of flowCommon StockSEC:0000892251-23-000182:0
65,653 shares@ US$255.485.2% of flowCommon StockSEC:0000950170-23-049302:0
53,385 shares@ US$274.764.5% of flowCommon StockSEC:0000892251-23-000145:0
49,347 shares@ US$220.852.1% of flowCommon StockSEC:0000892251-23-000070:0
58,681 shares@ US$220.462.5% of flowCommon StockSEC:0000892251-23-000068:0
31,648 shares@ US$221.831.3% of flowCommon StockSEC:0000892251-23-000044:0
57,426 shares@ US$154.591.8% of flowCommon StockSEC:0001567619-22-017774:0
Canonical exit: 21 Dec 2022 (T+90)
94,119 shares@ US$155.143.0% of flowCommon StockSEC:0001567619-22-017724:0
Canonical exit: 19 Dec 2022 (T+90)
62,516 shares@ US$149.581.9% of flowCommon StockSEC:0001567619-22-017631:0
Canonical exit: 15 Dec 2022 (T+90)
62,516 shares@ US$152.661.9% of flowCommon StockSEC:0001567619-22-017540:0
Canonical exit: 13 Dec 2022 (T+90)
62,515 shares@ US$167.582.1% of flowCommon StockSEC:0001567619-22-017414:0
Canonical exit: 11 Dec 2022 (T+90)
56,557 shares@ US$157.651.8% of flowCommon StockSEC:0001567619-22-017263:0
Canonical exit: 7 Dec 2022 (T+90)
56,557 shares@ US$147.591.7% of flowCommon StockSEC:0001567619-22-017171:0
Canonical exit: 5 Dec 2022 (T+90)
25 of 65 declarations
About Medpace Investors, LLC
Medpace Investors, LLC is Chief Executive Officer & Chairman of the Board of Medpace Holdings, Inc. The declarant has 65 filings in total, and across the 65 sampled filings between 2021-06-17 and 2024-03-08, buys amount to EUR 80782132 and sells to EUR 329040448, with selling as the modal transaction type.
